Alpha Teknova, Inc. (TKNO): EBITDA
-$10.63M
Year ended 2025-12-31
-$9.47M
Trailing 12 months to 2026-06-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$10.63M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$19.57M | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$29.90M | n/m | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | -$46.49M | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$9.12M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $6.71M | n/a | 2022-03-18, From 2020-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$10.63M | n/m |
| Immucell Corp (ICCC) | 2025-12-31 | $4.43M | +306.8% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$431.22M | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$7.80M | n/m |
| Biomerica Inc (BMRA) | 2026-05-31 | -$5.24M | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$48.93M | n/m |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | -$333.50M | n/m |
| Neogen Corp (NEOG) | 2026-05-31 | $94.70M | n/m |
| Volitionrx Ltd (VNRX) | 2025-12-31 | -$20.75M | n/m |
Compare TKNO, ICCC, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗